From: Cancer risk after renal transplantation in South Korea: a nationwide population-based study
All cancer | Total (%) | Male, N (%) | Female, N (%) |
---|---|---|---|
104 (100) | 63 (100) | 41 (100) | |
Thyroid (C73) | 24 (23.1) | 12 (19.0) | 12 (29.3) |
Kidney (C64) | 9 (8.7) | 7 (11.1) | 2 (4.9) |
Stomach (C16) | 7 (6.7) | 7 (11.1) | |
Liver (C22) | 6 (5.8) | 5 (7.9) | 1 (2.4) |
Lung (C34) | 6 (5.8) | 5 (7.9) | 1 (2.4) |
Breast (C50) | 6 (5.8) | 6 (14.6) | |
Leukemia (C91, C92) | 4 (3.8) | 2 (3.1) | 2 (4.9) |
Skin (C44) | 4 (3.8) | 3 (4.8) | 1 (2.4) |
Myeloma (C90) | 4 (3.8) | 3 (4.8) | 1 (2.4) |
Non-Hodgkin lymphoma (C83, C85) | 4 (3.8) | 3 (4.8) | 1 (2.4) |
Kaposi sarcoma (C46) | 3 (2.9) | 3 (4.8) | |
Cervix uteri (C53) | 3 (2.9) | 3 (7.3) | |
Prostate (C61) | 3 (2.9) | 3 (4.8) | |
Brain (C71) | 3 (2.9) | 1 (1.6) | 2 (4.9) |
Pancreas (C25) | 2 (1.9) | 2 (3.1) | |
Bladder (C67) | 2 (1.9) | 1 (1.6) | 1 (2.4) |
Rectum (C19, C20) | 2 (1.9) | 1 (1.6) | 1 (2.4) |
Parotid gland (C07) | 1 (0.1) | 1 (1.6) | |
Colon (C18) | 1 (0.1) | 1 (2.4) | |
Anus (C21) | 1 (0.1) | 1 (2.4) | |
Larynx (C32) | 1 (0.1) | 1 (1.6) | |
Corpus uteri (C54) | 1 (0.1) | 1 (2.4) | |
Ovary (C56) | 1 (0.1) | 1 (2.4) | |
Renal pelvis (C65) | 1 (0.1) | 1 (2.4) | |
Ureter (C66) | 1 (0.1) | 1 (2.4) | |
Other site | 4 (3.8) | 3 (4.8) | 1 (2.4) |